Fulcrum Therapeutics, Inc. (FULC)
NASDAQ: FULC · Real-Time Price · USD
3.770
+0.090 (2.45%)
Nov 13, 2026, 4:00 PM EST - Market closed
Fulcrum Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Financial | Truist Financial | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Aug 18, 2026 |
| Bank of America Securities | Bank of America Securities | Sell Reiterates $3 | Sell | Reiterates | $3 | -20.42% | Aug 7, 2026 |
| J.P. Morgan | J.P. Morgan | Sell Downgrades n/a | Sell | Downgrades | n/a | n/a | Jun 2, 2026 |
| H.C. Wainwright | H.C. Wainwright | Hold Downgrades $25 → $3 | Hold | Downgrades | $25 → $3 | -20.42% | Jun 2, 2026 |
| Leerink Partners | Leerink Partners | Hold Downgrades $24 → $4 | Hold | Downgrades | $24 → $4 | +6.10% | Jun 2, 2026 |
| Piper Sandler | Piper Sandler | Sell Downgrades $23 → $3 | Sell | Downgrades | $23 → $3 | -20.42% | Jun 2, 2026 |
| RBC Capital | RBC Capital | Hold Maintains $10 → $4 | Hold | Maintains | $10 → $4 | +6.10% | Jun 2, 2026 |